Policy | March 11, 2024
North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh
The institution will be spread over an area of more than 8 acres
The institution will be spread over an area of more than 8 acres
These approvals mark significant progress for Venus Remedies in expanding its market presence
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
The US FDA's clearance of the trial marks the first global registrational Phase III trial for olverembatinib in patients with CP-CML to be conducted.
Subscribe To Our Newsletter & Stay Updated
